Insightace Analytic Pvt. Ltd. projects the anti-aging therapeutics market will expand at a 17.62% CAGR from 2024–2031. Leveraging regenerative medicine, mTOR modulation, and senolytics, the report analyzes drivers like an aging population and commercialization trends to inform strategic stakeholders.
Key points
- Market value grows from USD 692.66 M (2023) to USD 2.53 B (2031) at 17.62% CAGR
- Segmented by molecule (biologics, small molecules) and mechanism (senolytic, mTOR modulators)
- North America leads with highest revenue share driven by advanced infrastructure and consumer demand
Why it matters: Forecasting robust growth highlights critical opportunities for biotech investors and innovators to shape next-generation age-reversal therapies.
Q&A
- What drives market growth?
- What are senolytics?
- Why is insurance coverage limited?
- What role does mTOR modulation play?
